20 Biggest Mid-Day Gainers For Monday

Endocyte, Inc. ECYT shares surged 70 percent to $2.39 after the company reported worldwide license of PSMA-617 from ABX GmbH.
Capricor Therapeutics Inc CAPR shares gained 33.9 percent to $4.06.
VirnetX Holding Corporation VHC shares jumped 29.5 percent to $5.05 after falling 2.50 percent on Friday.
Social Reality Inc SRAX shares climbed 27.6 percent to $3.19 after surging 31.58 percent on Friday. SRAX reported the acquisition of OpenDSP's Demand-Side Platform.
Quarterhill Inc QTRH jumped 23.5 percent to $1.63 after the company updated Q3 guidance. The company expects Q3 sales of $72.5 million to $82.5 million and adjusted EBITDA of $50 million to $56 million.
Alphatec Holdings Inc ATEC shares gained 23 percent to $2.78. Alphatec named Patrick Miles as Executive Chairman and Quentin Blackford as a member of the Board.
Synchronoss Technologies, Inc. SNCR rose 20.6 percent to $11.25 after the company disclosed Friday that it remains in active discussions with multiple parties.
Rigel Pharmaceuticals, Inc. RIGL jumped 18.5 percent to $3.01 after the company issued an update on FDA review of fostamatinib for ITP. The FDA has indicated it will not hold an Oncology Drugs AdCom meeting for fostamatinib.
ITUS Corp ITUS shares gained 14.8 percent to $3.02 after falling 24.86 percent on Friday. ITUS reported the completion of at-the-market offering.
Catabasis Pharmaceuticals Inc CATB jumped 14.8 percent to $2.43 after falling 4.93 percent on Friday.
Miragen Therapeutics, Inc. MGEN shares rose 14 percent to $10.43.
Trinity Industries Inc TRN shares gained 12.2 percent to $35.77. The U.S. Court Of Appeals for the Fifth Circuit ruled that Trinity Industries did not commit fraud.
AcelRx Pharmaceuticals Inc ACRX climbed 11.5 percent to $5.13 after gaining 5.75 percent on Friday.
Presbia PLC LENS shares rose 11 percent to $5.00.
Veritone Inc VERI shares surged 10.3 percent to $50.15 after climbing 23.24 percent on Friday.
Helios and Matheson Analytics Inc HMNY shares gained 7.2 percent to $13.60 after surging 16.74 percent on Friday.
Myomo Inc MYO rose 6.7 percent to $6.40. H.C. Wainwright initiated coverage on Myomo with a Buy rating.
Sarepta Therapeutics Inc SRPT gained 6.1 percent to $48.10. Morgan Stanley upgraded Sarepta Therapeutics from Equal-Weight to Overweight.
Seattle Genetics, Inc. SGEN rose 4.4 percent to $56.78 as the company disclosed that it has received the FDA Breakthrough Therapy Designation for ADCETRIS in frontline advanced Hodgkin lymphoma.
Alnylam Pharmaceuticals, Inc. ALNY rose 3.5 percent to $121.54. Goldman Sachs upgraded Alnylam Pharmaceuticals from Neutral to Buy.